Showing results (91-100 of 711) with videos related to
Sort By:
Pageof 72
Environmental Health Perspectives|June 3, 1999
Biomarkers of environmental tobacco smoke exposureN L BenowitzCiba Foundation Symposium|January 1, 1990
Pharmacokinetic considerations in understanding nicotine dependenceN L BenowitzPharmacology & Toxicology|January 1, 1993
Clinical pharmacology and toxicology of cocaineN L BenowitzClinical Pharmacology and Therapeutics|June 1, 1984
Blood cotinine levels as indicators of smoking treatment outcomeS M Hall, R I Herning, R T Jones, et al.Clinical Pharmacology and Therapeutics|August 13, 2013
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokersD A Dempsey, G St Helen, P Jacob, et al.JAMA|July 11, 1986
Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettesN L Benowitz, P Jacob, L Yu, et al.The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Ethnic differences in N-glucuronidation of nicotine and cotinineN L Benowitz, E J Perez-Stable, I Fong, et al.Annals of Internal Medicine|April 15, 1989
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactionsB L Lee, I Medina, N L Benowitz, et al.Addiction (Abingdon, England)|March 1, 1997
Saliva cotinine levels as a function of collection methodN G Schneider, P Jacob, F Nilsson, et al.Pageof 72